 | Up a level |
Journal Article
Coutre, Steven E., Furman, Richard R., Sharman, Jeff Porter, Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline Claudia, Zelenetz, Andrew David, Kipps, Thomas J., Flinn, Ian, Ghia, Paolo, Eradat, Herbert Aaron, Ervin, Thomas J., Lamanna, Nicole 
ORCID: 0000-0003-3331-9491, Coiffier, Bertrand, Pettitt, Andrew, Kim, Yeonhee, Jahn, Thomas Michael, O'Brien, Susan Mary and Hallek, Michael J.
(2014).
Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL.
J. Clin. Oncol., 32 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Ghia, Paolo, O'Brien, Susan Mary, Hillmen, Peter, Furman, Richard R., Coutre, Steven E., Sharman, Jeff Porter, Cheson, Bruce D., Pagel, John M., Barrientos, Jacqueline Claudia, Zelenetz, Andrew David, Kipps, Thomas J., Flinn, Ian, Eradat, Herbert Aaron, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Hallek, Michael J., Coiffier, Bertrand, Pettitt, Andrew, Ye, Wei, Jahn, Thomas Michael and Wagner, Lynne I.
(2014).
Health-related quality of life (HRQL) impact of idelalisib (IDELA) in patients (pts) with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results.
J. Clin. Oncol., 32 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Kreuzer, Karl-Anton, Furman, Richard, Stilgenbauer, Stephan, Dubowy, Ronald, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweisz, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O'Brien, Susan, Pettitt, Andrew and Hallek, Michael (2017). Improved overall survival of relapsed chronic lymphocytic leukemia (CLL) patients exhibiting a complex karyotype and treated with idelalisib plus rituximab. Leuk. Lymphoma, 58. S. 167 - 169. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Pagel, John M., Coutre, Steven E., Furman, Richard R., Sharman, Jeff P., Cheson, Bruce D., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian W., Ghia, Paolo, Eradat, Herbert A., Ervin, Thomas, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Coiffier, Bertrand, Pettitt, Andrew, Li, Xiaoming, Jahn, Thomas M., O'Brien, Susan M. and Hallek, Michael J.
(2015).
Second Interim Analysis of a Phase 3 Study Evaluating Idelalisib and Rituximab for Relapsed Chronic Lymphocytic Leukemia.
Clin. Lymphoma Myeloma Leuk., 15.
S. S201 - 2.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669
Rose-Zerilli, Matthew, Wojdacz, Tomasz, Amarasinghe, Harindra, Kadalayil, Latha, Blakemore, Stuart, Parker, Helen, Bryant, Dean, Larrayoz, Marta, Clifford, Ruth, Robbe, Pauline, Davis, Zadie, Else, Monica, Howard, Dena, Steele, Andrew, Brandell, Richard Rosenquist, Collins, Andrew, Pettitt, Andrew, Hillmen, Peter, Plass, Christoph, Schuh, Anna, Catovsky, Daniel, Oscier, David, Oakes, Christopher and Strefford, Jonathan (2020). Clinico-biological significance of DNA methylation in chronic lymphocytic leukaemia patients: results from three UK clinical trials. Leuk. Lymphoma, 61. S. 100 - 103. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403